Catheter Stabilization Device Market: Market Size & Forecast 2026

Catheter stabilization devices are medical accessories engineered to secure intravascular catheters in place, reducing the risk of accidental dislodgement, infiltration, and catheter-related bloodstream infections. The market spans a broad range of product types, including adhesive securement dressings, suture-based stabilizers, and integrated securement devices (ISDs) that combine catheter fixation with vascular access. Global demand is supported by the massive and growing utilization of central venous catheters (CVCs) and peripheral intravenous catheters (PIVCs) across hospitals, ambulatory surgical centers, and home care environments.

• •Market valued at $1.82 billion globally in 2025
• •Projected CAGR of 5.61% through the early 2030s
• •Encompasses adhesive, suture, and integrated securement solutions for CVC, PICC, and PIV lines

Catheter dislodgement remains one of the most prevalent complications in intravascular therapy, leading to unplanned catheter replacement, treatment delays, and increased risk of infection. Clinical guidelines and consensus standards increasingly recommend integrated securement devices and alternative anchoring mechanisms over traditional suturing, particularly in higher-income nations where adoption rates are notably higher. The broader growth of extended-dwell catheter programs, designed to reduce peripheral IV restarts and improve patient satisfaction, further amplifies demand for compatible stabilization infrastructure.

• •High prevalence of catheter dislodgement drives demand for proven securement solutions
• •Clinical consensus and hospital safety guidelines increasingly endorse integrated securement devices
• •Expansion of extended-dwell and midlines catheter programs boosts secondary stabilizer demand

The market is typically segmented by product type, including adhesive-based devices, suture-based devices, and subcutaneous anchor devices, as well as by catheter type (CVC, PICC, PIVC), end-user setting, and geography. North America currently accounts for the largest share, supported by advanced healthcare infrastructure, strong clinical guideline adoption, and favorable reimbursement frameworks. Europe and the Asia-Pacific region are also significant markets, with the latter expected to see accelerated growth as healthcare systems expand vascular access capacity and adopt international best practices.

• •Product segments include adhesive securement dressings, suture-based stabilizers, and subcutaneous anchoring devices
• •North America leads in market share, with strong adoption of ISDs and clinical protocol integration
• •Asia-Pacific is an emerging growth region driven by expanding hospital infrastructure and catheter utilization

What are the recent trends and outlook?

Looking ahead, the market is expected to benefit from continued clinical research validating the efficacy of integrated securement devices, healthcare-acquired infection reduction initiatives, and macroeconomic tailwinds in medical device spending. Microplastics concerns and evolving biocompatibility standards are also shaping material innovation in securement products. Long-term growth will likely be reinforced by CMS and other payer organizations emphasizing value-based care outcomes that reduce preventable complications, a framework in which catheter stabilization plays a demonstrable cost-saving role.

• •Ongoing clinical research continues to shift practice toward integrated securement over sutures
• •Healthcare-acquired infection prevention and value-based care reimbursement models support market expansion
• •Material innovation addressing biocompatibility and microplastics concerns is an emerging product development focus